Key players of extracorporeal membrane oxygenation machine market were Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.). These companies together contributed ~68.8% of the global market in 2016. On basis of modality, market segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV).
- Agency -.
Complete report on Extracorporeal Membrane Oxygenation Machine Market spread across 129 Pages, Profiling 11 Companies and Supported with 78 Tables and 31 Figures is now available at www.rnrmarketresearch.com/extracor…arket-report.html .
The extracorporeal membrane oxygenation machine market poised to reach USD 305.3 Million by 2021, at a CAGR of 4.3% during forecast period of 2016 to 2021. The venovenous (VV) segment is expected to account for largest share of market in 2016.
Large share of this segment is mainly attributed to high incidence of respiratory failure, rising lung transplants, & technological advancements.
- Agency -.
- Extracorporeal membrane oxygenation machine Systems and related devices manufacturing companies
- Suppliers and distributors of ECMO systems and components
- Hospitals, Extracorporeal membrane oxygenation machine centers, and medical colleges
- Teaching hospitals and academic medical centers (AMCs)
- Government bodies and regulatory authorities
- Business research and co
The extracorporeal membrane oxygenation machine market growth of can be contributed to the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of extracorporeal membrane oxygenation machine centers, conferences & training programs to increase awareness, and technological advancements.
Extracorporeal membrane oxygenation machine market North America expected to account for largest share in 2016, followed by Europe, Asia-Pacific, & Rest of the World (RoW). Large share of North American region can be attributed to favorable reimbursement scenario, rising incidence of lung cancer, & presence of a large number of ECMO centers in U.S.
Asia-Pacific region expected to witness highest growth rate in forecast period.
1 Extracorporeal Membrane Oxygenation (ECMO) Machine: Market Overview
2 Geographic Analysis: ECMO Machine Market, By Modality (2016)
3 ECMO Machine Market, By Application, 2016 vs 2021
4 Geographic Snapshot of the ECMO Machine Market
Key players of extracorporeal membrane oxygenation machine market were Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.). These companies together contributed ~68.8% of the global market in 2015.
The other players of the market are XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc.
(Germany), and EUROSETS S.r.l. (Italy).
The extracorporeal membrane oxygenation machine market expected to witness highest growth in Asia-Pacific region, with emphasis on China, Japan, India, & Rest of Asia-Pacific in forecast period. Factors such as favorable reimbursement scenario in Japan, rising cardiovascular diseases in China, growing application.
Adoption of extracorporeal membrane oxygenation machine in India, & rising cardiopulmonary disorders in Australia are driving growth of market in this region. Global market is segmented on basis of modality, application, and region.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: